No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Established in 2015 and based in Minato, Japan, this company is dedicated to exploring and advancing CAR-T cell technology for use in cancer immunotherapy treatments.
www.noile-immune.comNo one on the platform currently holds 4893.T.
No tracked institution reports a position in 4893.T as of their last filing.
No one on the platform has traded 4893.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| Rev. Growth % | -34.1% | -44.8% | ||||
| Profit Margin % | -15870.7% | -5958.1% | ||||
| Free Cash Flow Margin % | 0.0% | -2553.2% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $300M | +0.0% | $-18.33 | $-18.33–$-18.33 | — | 1 |
| 2027 | $300M | +0.0% | $-24.00 | $-24.00–$-24.00 | — | 1 |
| 2028 | $3.1B | +933.3% | $31.00 | $31.00–$31.00 | — | 1 |
| 2029 | $300M | -90.3% | $-28.00 | $-28.00–$-28.00 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 6 of the last 7 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-13 | $-5.51 | $-5.04 | +8.5% |
| 2026-05-14 | $-5.05 | $-3.54 | +29.9% |
| 2026-02-13 | $-5.42 | $-4.36 | +19.6% |
| 2025-09-30 | $-11.04 | $-4.47 | +59.5% |
| 2025-06-30 | $-5.70 | $-3.95 | +30.7% |
| 2025-02-14 | $-20.87 | $-4.09 | +80.4% |
| 2024-11-14 | $15.79 | $-2.40 | -115.2% |
| +0.00% |
| $7.5B |
| — |
| 4564.TOncoTherapy Science, Inc. | $23.00 | +4.55% | $9.2B | — |
| 4583.TChiome Bioscience Inc. | $88.00 | +1.15% | $6.4B | — |
Source: Financial Modeling Prep · peers by sector/industry